Cross Country Healthcare Inc (CCRN) Stock Forecast & Price Target
Cross Country Healthcare Inc · NASDAQ
$13.25+0.00 (+0.00%)
15-min delayed · Jul 24, 8:00 AM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Cross Country Healthcare Inc, 0 rate it Buy or better, 5 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets span $9.00 to $14.00, a moderate spread. The average target of $12.55 sits 5% below the current $13.25. The rating mix has stayed broadly stable, with Buy-side ratings easing from 2 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.04 next quarter toward $0.29 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Hold
Strong Buy00%
Buy00%
Hold5100%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Cross Country Healthcare Inc.
As of Jul, 0 of 5 firms rate CCRN a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CCRN EPS & revenue forecast
EPS · NEXT QUARTER
$0.04
Range $0.03 – $0.06 · 6 analysts · +50% YoY
Next period, 6 analysts expect Cross Country Healthcare Inc to earn $0.04 a share (range $0.03 – $0.06), versus $0.03 a year earlier. Full-year consensus is $0.11, growing to $0.29 the year after.
REVENUE · NEXT QUARTER
$249.7M
Range $242.8M – $261.1M · 6 analysts · -0% YoY
Revenue is expected to reach $249.7M (range $242.8M – $261.1M), -0.1% year-over-year. Full-year consensus is $989.0M, rising to $1.0B next year.
Top analysts covering Cross Country Healthcare Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CCRN.
#1
BS
Bill Sutherland
Benchmark · Rank #52
Hold
No targeton CCRN
Overall win rate
44%
+ Follow
#2
Constantine Davides
JMP Securities · Rank #225
Hold
No targeton CCRN
Overall win rate
34%
+ Follow
#3
Kevin Steinke
Barrington Research · Rank #272
Hold
$13.25+0.0% to target
Overall win rate
33%
+ Follow
#4
Tobey Sommer
Truist Securities · Rank #283
Hold
$13.25+0.0% to target
Overall win rate
35%
+ Follow
#5
MP
Michael Piccolo
Wedbush
Hold
$13.25+0.0% to target
Coverage
—
+ Follow
CCRN stock forecast FAQ
What is CCRN's average 12-month price target?+
The 4 analysts with a live target average $12.55 for Cross Country Healthcare Inc over the next 12 months, ranging from a $14.00 high to a $9.00 low.
Is CCRN stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 5 analyst ratings, 0 are Buy or Strong Buy, 5 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CCRN?+
The Street-high target is $14.00, and the Street-low is $9.00 (UBS). The average of all 4 active targets is $12.55.
How many Wall Street analysts cover CCRN?+
5 analysts have an active rating on Cross Country Healthcare Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering CCRN?+
Among analysts who currently cover CCRN, Bill Sutherland of Benchmark has the strongest overall Quantellect track record (Rank #52). Their current call is Hold.
What is Cross Country Healthcare Inc's projected EPS for next quarter?+
The consensus estimate is $0.04 per share (range $0.03 – $0.06) across 6 analysts. Full-year EPS is projected at $0.11, rising to $0.29 the following year.
How much revenue is Cross Country Healthcare Inc expected to report next quarter?+
Consensus revenue is $249.7M (range $242.8M – $261.1M). Full-year revenue is projected at $989.0M, growing to $1.0B next year.
Have analysts been upgrading or downgrading CCRN lately?+
As of Jul, 0 of 5 firms rate CCRN a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CCRN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
